2National Institutes of Health(NIH). National Heart, Lung and Blood Institute (NHLBI)/World Health Organization (WHO). Global strategy for asthma management and prevention. Global initiative for asthma. No.02-3659. NIH Publication,2002.81-82.
3Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The gaining optimal asthma control study. Am J Respir Crit Care Med, 2004,170:836-844.
4推广《全球哮喘防治创议》国际研讨会纪要[J].哮喘杂志,2000,6(1):59-59.
5WHO/NHLBI Workshop Report. Global initiative for asthma management and prevention: pocket guide for asthma management and prevention in children. Maryland: National Institute of Health, National Heart, Lung, and Blood Institute, 2002. 6-9.
6Hogg JC,James AL,Pare PD. Evidence for inflammation in asthma. Am Rev Respir Dis, 1991,143:S39-S42.
7Adams N,Bestall J,Jone PW. Inhaled fluticasone at different doses for chronic asthma. Cochrane Database Syst Rev,2002,(1):CD003534.
8Adams N,Bestall J,Jones PW. Inhaled fluticasone proprionate for chronic asthma. Cochrane Database Syst Rev,2001,(3):CD003135.
9Kamada AK, Szefler SJ, Martin KJ, et al. Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network. Am J Respir Crit Care Med, 1996,153(6 Pt 1):1739-1748.
10Pauwels RA, Pedrson S, Busse WW, et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet, 2003, 361:1071-1076.
